FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum.
Miriam S ReuterAngelika RiessUte MoogTracy A BriggsKate E ChandlerAnita RauchMiriam StampferKatharina SteindlDieter GläserPascal Josetnull nullMandy KrumbiegelHarald RabeUta Schulte-MattlerPeter BauerStefanie Beck-WödlJürgen KohlhaseAndré ReisChristiane ZweierPublished in: Journal of medical genetics (2016)
By identifying intragenic deletions or mutations in 14 individuals from eight unrelated families with variable developmental delay/cognitive impairment and speech and language deficits, we considerably broaden the mutational and clinical spectrum associated with aberrations in FOXP2.